Article -> Article Details
Title | Delirium Market Research, Size, Value Share, Latest Trend, Key Player Review and Forecast |
---|---|
Category | Fitness Health --> Health Articles |
Meta Keywords | Delirium Market, Delirium Market Size, Delirium Market Industry, Delirium Market, Delirium Market Research, Delirium Market Analysis, |
Owner | Vaibhav |
Description | |
The Delirium Market is expected to reach USD
365.7 Million by 2030 at 5.70% CAGR during the forecast period 2022-2030. Delirium is a
neurological (nervous system) condition and is a serious disturbance in mental
abilities that causes mental confusion and emotional disruption. Delirium can
be caused due to various factors such as older age, exposure to certain
medications, alcohol abuse, surgery or other medical procedures, factors such
as exposure to toxic or infectious agents, physical trauma, diet, and
behavioral and occupational factors. Delirium Market Research Overview Analysis By Type (Hyperactive,
Hypoactive, Mixed), Treatment (Antipsychotics, Supportive Care), Diagnosis
(Laboratory Tests, Imaging Tests, Physical Examination), End-User (Hospitals,
Specialty Centers) Major Key
Players: Some of Key Players are Dr. Franz Kohler Chemie GmbH, Fraser
Health, Gaia BioPharma Ltd., Novartis AG, Pfizer, Inc., Regenstrief Institute,
Inc., and Air Liquide Sante International, among others. Segment Analysis The global Delirium Market Research Report
by type, treatment, diagnosis, and end-user. On the basis of type, the market is segmented into
hyperactive, hypoactive, and mixed. On the basis of diagnosis, the market is segmented
into laboratory tests, imaging tests, and physical examination. On the basis of
laboratory tests, it is further sub-segmented into blood tests and urine tests.
On the basis of imaging tests, it is further sub-segmented into brain-imaging
tests. On the basis of treatment, the market is segmented
into antipsychotics and supportive care. On the basis of treatment,
antipsychotics is further sub-segmented into risperidone, olanzapine, and
quetiapine. On the basis of end-user, the market is segmented
into specialty centers, hospitals, and research centers. Regional Analysis The Americas dominates the global
delirium market owing to the increasing aging population and increasing rate of
neurological conditions. Additionally, the increasing government initiatives
and awareness programs are likely to enhance the growth of delirium in the
North American region. Similarly, increasing government healthcare costs, along
with the increasing awareness among population regarding mental health is
expected to drive the growth of the delirium market in North America. For
instance, iDelirium, a federation of 3 delirium societies (American Delirium
Society, European Delirium Society, and Australasian Delirium Association) has
launched various awareness programs across the country to spread awareness
regarding delirium and its effects. Europe accounts for the second
largest market due to increasing aging mass and increasing neurological
disorders. Additionally, the improving government funding and increasing
healthcare infrastructure along with the increasing demand for technologically
advanced treatment are driving the growth of delirium market in Europe. For
instance, Eurostat estimated that over 19.2% of the population in Europe was
aged 65 and above. This rising older population is likely to drive the growth
of the delirium market. Asia Pacific is the fastest
growing market for delirium whose growth is attributed to the increasing
population which in turn increases the overall patient population and rising
population affected by post-surgical disorders. India and China are the primary
contributors to the market growth due to the rising demand for advanced and
newer treatments and rising development of healthcare infrastructure in these
regions. On the other hand, the Middle
East and Africa is expected to witness a restricted growth due to limited
access and affordability of the healthcare system and lack of awareness among
individuals. In the Middle East, the growth of the market is driven by the
growing awareness regarding neurological disorders and expanding healthcare
scenario. About Market Research
Future At Market Research Future (MRFR), we enable our
customers to unravel the complexity of various industries through our Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services. MRFR team have supreme objective to provide the
optimum quality market research and intelligence services to our clients. Our
market research studies by products, services, technologies, applications, end users,
and market players for global, regional, and country level market segments,
enable our clients to see more, know more, and do more, which help to answer
all their most important questions. In order to stay updated with technology and work
process of the industry, MRFR often plans & conducts meet with the industry
experts and industrial visits for its research analyst members. Contact us: Market Research Future
(part of Wantstats Research and Media Private Limited), 99 Hudson Street, 5Th Floor, New York, New York 10013 United States of America +1 646 845 9312 |